HIV 1 News and Research

RSS

VGTI, OHSU's new vaccine candidate may fight against HIV

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute has developed a vaccine candidate in non-human primates that may eventually lead to a vaccine against Human Immunodeficiency Virus.

12 May 2011

LogisticsWeek examines PEPFAR's Supply Chain Management System

LogisticsWeek looks at how "PEPFAR's Supply Chain Management System, a project made up of 13 health and development institutions working to procure and provide quality essential medicines at affordable prices," has been able to assist countries in quickly scaling up HIV/AIDS treatment.

12 May 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

11 May 2011

Roundup: Calif.'s Central Valley facing health problems; Baltimore launches campaign to attack causes of preventable deaths

A health care crisis is sweeping the Central Valley, devastating middle-class and poor families and threatening to overwhelm the region's fragile safety net. The deep recession has pushed the ranks of the uninsured here to unprecedented levels. At the same time, a dire state budget deficit has forced lawmakers to drastically scale back or eliminate key health care programs for the state's poorest residents.

11 May 2011

MIGMH awarded $2.1 million grant for STD/HIV regional educational center

The Mississippi Institute of Geographic and Minority Health (MIGMH) at the University of Mississippi Medical Center (UMMC) has been awarded a three-year, $2.1 million grant to operate a regional educational center for the Centers for Disease Control and Prevention (CDC) to teach interventions that prevent the spread of sexually transmitted diseases and HIV.

10 May 2011

HIV drugs can be used to target malaria and other parasitic diseases

Drugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from Cardiff University.

10 May 2011

More than half of all adolescents accept free rapid HIV test after risk assessment survey

Although the Centers for Disease Control and Prevention recommends routine HIV testing for everyone between the ages of 13-64 as part of their regular medical care, testing rates remain low among adolescents.

10 May 2011

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

"Cracking the Safe: Advances in HIV/AIDS Prevention and Treatment" is a one-day symposium at the New York Academy of Sciences examining issues facing researchers working towards the development of an HIV/AIDS vaccine, including updates on current challenges and solutions.

10 May 2011

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

Starpharma Holdings Limited today announced that it has signed a licence agreement with Okamoto Industries Inc in relation to the VivaGel(r)-coated condom for the Japanese market. Okamoto is the market leader for condoms sold in Japan, the world's second largest condom market.

10 May 2011

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

9 May 2011

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."

7 May 2011

New book explores the hidden world of viruses

"Carl Zimmer is one of the best science writers we have today. A Planet of Viruses is an important primer on the viruses living within and around all of us-sometimes funny, other times shocking, and always accessible. Whether discussing the common cold and flu, little-known viruses that attack bacteria or protect oceans, or the world's viral future as seen through our encounters with HIV or SARS, Zimmer's writing is lively, knowledgeable, and graced with poetic touches."-Rebecca Skloot, author of The Immortal Life of Henrietta Lacks.

7 May 2011

Latest research on HIV immunity can help develop vaccine

Latest insights into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease, a University of Melbourne, Australia study has found.

7 May 2011

Recent releases in Global Health

"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".

7 May 2011

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

The American Gastroenterological Association Research Foundation has announced its 2011 research scholars. The grants have been awarded to four outstanding young gastroenterologists who promise to make significant strides in the field of gastrointestinal research.

6 May 2011

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.

6 May 2011

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). The researchers found that neutralizing antibodies generated by immunization were associated with protection against SIV infection.

6 May 2011

Study examines community-based HIV testing programs in Africa, Southeast Asia

If you want to improve HIV testing rates in remote rural areas, get the community involved, says UCLA's Thomas Coates, who has directed a new study examining HIV testing programs in communities in Africa and Southeast Asia.

6 May 2011

HIV 1 News and Research

VGTI, OHSU's new vaccine candidate may fight against HIV

LogisticsWeek examines PEPFAR's Supply Chain Management System

Inovio first quarter total revenue increases to $3.1 million for 2011

Roundup: Calif.'s Central Valley facing health problems; Baltimore launches campaign to attack causes of preventable deaths

MIGMH awarded $2.1 million grant for STD/HIV regional educational center

HIV drugs can be used to target malaria and other parasitic diseases

More than half of all adolescents accept free rapid HIV test after risk assessment survey

New York Academy of Sciences to host symposium on cutting-edge HIV/AIDS vaccine research

Starpharma inks licence agreement in Japan with Okamoto for VivaGel-coated condoms

Uganda: First vaccination for GMZ2 malaria vaccine trial

World's first urine-based tuberculosis diagnostics tool

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

New book explores the hidden world of viruses

Latest research on HIV immunity can help develop vaccine

Recent releases in Global Health

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Study examines community-based HIV testing programs in Africa, Southeast Asia

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News